• Keine Ergebnisse gefunden

Endothelial AMP-Activated Kinase α1 Phosphorylates eNOS on Thr495 and Decreases Endothelial NO Formation

N/A
N/A
Protected

Academic year: 2022

Aktie "Endothelial AMP-Activated Kinase α1 Phosphorylates eNOS on Thr495 and Decreases Endothelial NO Formation"

Copied!
3
0
0

Wird geladen.... (Jetzt Volltext ansehen)

Volltext

(1)

1

Endothelial AMP-Activated Kinase α1

Phosphorylates eNOS on Thr495 and Decreases Endothelial NO Formation

Nina Zippel 1, Annemarieke E. Loot 1, Heike Stingl 1,2,Voahanginirina Randriamboavonjy 1,2, Ingrid Fleming1,2 and Beate Fisslthaler1,2,*

1 Institute for Vascular Signalling, Centre for Molecular Medicine, Johann Wolfgang Goethe University, 60590 Frankfurt, Germany; NZippel@gmx.de (N.Z.); a.loot@certe.nl (A.E.L.); Stingl@vrc.uni-frankfurt.de (H.S.); Voahangy@vrc.uni-frankfurt.de (V.R.); fleming@em.uni-frankfurt.de (I.F.)

2 DZHK (German Centre for Cardiovascular Research) partner site RhineMain, Theodor Stern Kai 7, 60590 Frankfurt, Germany

* Correspondence: fisslthaler@vrc.uni-frankfurt.de; Tel.: +49-69-6301-6994 Supplementary Materials:

Figure S1. Vascular function in carotid arteries from wild-type (WT) and AMPKα1−/− mice. (A) Contraction induced by KCl (80 mmol/L), (B) concentration response curves to phenylephrine (PE), and relaxation curves to (C) acetylcholine (ACh) or (D) sodium nitroprusside (SNP) in PE-contracted vessels. The graphs summarize data obtained from 7 animals in each group.

Supplementary Figure A1. Vascular function in carotid arteries from wild-type (WT) and AMPK1-/- mice. (A) Contraction induced by KCl (80 mmol/L), (B) concentration response curves to phenylephrine (PE), and relaxation curves to (C) acetylcholine (ACh) or (D) sodium nitroprusside (SNP) in PE-contracted vessels. The graphs summarize data obtained from 7 animals in each group.

-10 -9 -8 -7 -6 0

20 40 60 80 100

WT

1-/-

[ACh] (log mol/L)

Relaxation (% PE)

-10 -9 -8 -7 -6 0

20 40 60 80 100

WT

1-/-

[SNP] (log mol/L)

Relaxation (% PE)

WT 1-/- 0.0

0.5 1.0

1.5 0.1647

Force (mN/mm)

A

C D

-9 -8 -7 -6 -5

0 50 100

150 WT

1-/-

[PE] (log mol/L)

Contraction (%KCl)

B

looks like a significant effect – but if this is L-NAME sensitive then it’s the same as in the aorta!

Do we really need data from the carotids?

It not essential but we have it so we

may as well show it

(2)

2

Figure S2. Endothelial cell specific deletion of AMPKα1. (A) AMPKα1 expression in freshly isolated pulmonary endothelial cells from AMPKα1EC or Cre−/− (wild-type; WT) mice. (B) Expression of eNOS, AMPKα1 and AMPKα2 in aortic ring lysates from WTor AMPKα1EC (EC)mice. (A) The blots presented are representative of 12 additional experiments using 2 mice per group.

Figure S3. Effect of endothelial specific deletion of AMPKα2 on vascular reactivity of aortic rings (A) Dose dependent contraction to PE of wild-type (open symbols) or AMPKα2EC mice (closed symbols).

(B) Relaxation curves of aortic rings to acetylcholine (ACh) after PE constriction of wild-type (open Supplementary Figure A2.Endothelial cell specific deletion of AMPK1. (A)

AMPK1 expression in freshly isolated pulmonary endothelial cells from AMPK1ECor Cre-/- (wild-type; WT) mice. (B) Expression of eNOS, AMPK1 and AMPK2 in aortic ring lysates from WT or AMPK1EC (EC) mice. (A) The blots presented are representative of 12 additional experiments using 2 mice per group.

eNOS - AMPK1 - AMPK2 -

EC WT

AMPK1 -

A

B

WT EC

eNOS -

b-actin -

EC WT

-55 -72 kDa

-55 -72 -130

-55 -72 kDa -36

-130

-9 -8 -7 -6 -5

0 .0 0 .5

1 .0 W T

2E C

[ P E ] ( lo g m o l/ L )

Force (g)

-1 0 -9 -8 -7 -6

0 2 0 4 0 6 0 8 0 1 0 0

W T

2E C

[ S N P ] ( lo g m o l/L )

Relaxation (% PE)

-9 -8 -7 -6 -5

0 2 0 4 0 6 0 8 0

1 0 0 2E C

W T

[ A C h ] ( lo g m o l/ L )

Relaxation (%PE)

A

B C

Supplementary Figure A3: Effect of endothelial specific deletion of AMPK 2 on vascular reactivity of aortic rings (A) Dose dependent contraction to PE of wild-type (open symbols) or AMPK2

EC

mice (closed symbols). (B) Relaxation curves of aortic rings to acetylcholine (ACh) after PE constriction of wild-type (open symbols) or AMPK2

EC

mice (closed symbols).

(C) Dose-dependent relaxation to SNP. The graphs summarize data obtained from 6 animals

in each group.

(3)

3

symbols) or AMPKα2EC mice (closed symbols). (C) Dose-dependent relaxation to SNP. The graphs summarize data obtained from 6 animals in each group.

Figure S4. Effect of AMPK activators on the relaxation of aortic rings. (A,B) Concentration dependent effects of resveratrol (A) and amurensin G (B) on vascular tone in phenylephrine preconstricted aortic rings from wild-type (WT) and AMPKα1EC (α1EC) mice; n = 6 animals in each group. (C,D) Time- dependent effects of PT-1 (C, 30 µmol/L) and 991 (D; 30 µmol/L) on vascular tone in phenylephrine preconstricted aortic rings from wild-type (WT) and AMPKα1EC (α1EC) mice; n = 4 animals in each group. (E) Effects of the AMPK activators on the phosphorylation of AMPK (on Thr172) and ACC (Ser79) in endothelial cells isolated from aortic rings from wild-type mice. Experiments were performed in the absence (Basal) and presence of 991 (30 µmol/L), AICAR (0.5 mmol/L) or PT-1 (30 µmol/L) for 60 min. Comparable results were obtained in 3 additional independent experiments.

Supplementary Figure A4.

Effect of AMPK activators on the relaxation of aortic rings.

(A&B) Concentration dependent effects of resveratrol (A) and amurensin G (B) on vascular tone in phenylephrine preconstricted aortic rings from wild-type (WT) and AMPK1

EC

(1EC) mice; n=6 animals in each group. (C&D) Time-dependent effects of PT-1 (C, 30 µmol/L) and 991 (D; 30 µmol/L) on vascular tone in phenylephrine preconstricted aortic rings from wild-type (WT) and AMPK1

EC

(1EC) mice; n=4 animals in each group. (E) Effects of the AMPK activators on the phosphorylation of AMPK (on Thr172) and ACC (on

???) in

endothelial cells isolated from aortic rings from wild-type mice. experiments were performed in the absence (Basal) and presence of 991 (30 µmol/L), AICAR (0.5 mmol/L) or PT-1 (30 µmol/L) for 60 minutes. Comparable results were obtained in 3 additional independent experiments.

PT-1 PT-1

- pAMPK -

b-actin

AICAR Resv Basal Basal 991 991

10 60 10 60 min

0 5 1 0

-1 0 0 -5 0 0

W T

W T + L - N A M E

1E C

1E C + L - N A M E [A m u re n s in G ] (µ g /m l)

Relaxation (%PE)

0 5 0 1 0 0

-1 0 0 -5 0 0

W T

W T + L - N A M E

1E C

1E C + L - N A M E [R e s v e ra tro l] (µ m o l/L )

Relaxation (%PE)

A B

0 1 0 6 0

- 1 0 0 - 5 0 0

T im e ( m in )

Relaxation (%PE)

W T - S O L

W T + L - N A M E

1E C

1E C + L - N A M E

0 1 0 6 0

- 1 0 0 - 5 0 0

T im e ( m in )

Relaxation (%PE)

W T - S O L

W T + L - N A M E

1E C

1E C + L - N A M E

C D

E Basal 991 AICAR Basal

-pACC

-pAMPK

-b-actin

PT-1

Referenzen

ÄHNLICHE DOKUMENTE

Diese Annahme wird unterstützt durch Experimente, in denen beispielsweise die Steigerung der Expression von VEGF auf m-RNA-Ebene unter erniedrigtem

Having characterized the effects of two representative actin binding compounds on general transcription-associated processes (4.1) as well as on nuclear actin structure and

Analysis of the 2-year VISION trial data revealed that mean visual acuity was maintained in patients receiving 0.3 mg pegaptanib, and the proportion of patients losing fewer than

Endothelial dysfunction has numerous causes: Aging is associ- ated with increased formation of contracting factor and decreased relaxing factor; denudation, such as by

VEGF binding to the VEGFR extracellular domains induces dimerization of receptor monomers followed by autophosphorylation of specific tyrosine residues in the receptor

Using a transgenic mouse model with beta-galactosidase (β-gal) expression confined to the vascular endothelium (Tie2-LacZ mice) and the help of β-gal TCR

Der Lebenslauf wurde aus der elektronischen Version der Arbeit entfernt.. The curriculum vitae was removed from the electronic version of

As the global deletion of AMPK seemed to affect vascular smooth-muscle contraction rather than NO-mediated relaxation, animals lacking the AMPK α 1 or AMPK α 2 subunits specifically